Ulge Umut 13D and 13G filings for Neoleukin Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:06 pm Purchase | 2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | Ulge Umut | 156,387 7.300% | 9,115 (+6.19%) | Filing |
| 2021-02-12 4:27 pm Sale | 2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | Ulge Umut | 147,272 6.980% | -8,323 (-5.35%) | Filing |